The DayspringTM system is a FDA cleared, prescription-only medical device indicated for the treatment of lymphedema, venous insufficiency, and reducing wound healing time.1
1 Refer to Directions for Use for full prescribing information
The Dayspring system is an FDA cleared, prescription-only medical device indicated forthe treatment of lymphedema, venous insufficiency, and reducing wound healing time.
.png)
Dayspring is built on an innovative, mobile platform that uses patented Flexframe™ technology3 to provide active sequential gradient compression.
2 Investigators involved in clinical studies sponsored by Koya Medical
3 Spring-like segments embedded with highly durable shape memory alloy that contract and relax when powered by the Dayspring controller
The Koya app is designed with clinicians and patients in mind to support personalized treatments.
Get in touch to learn more or schedule a virtual or in-person demonstration.
Dayspring has been clinically studied in over 40 patients. In these studies, Dayspring significantly improved quality of life, received high patient satisfaction, and maintained limb volume.
Stanley G. Rockson, Pinar Karaca-Mandic, Roman Skoracki, Karen Hock, Michelle Nguyen, Kristin Shadduck, Phyllis Gingerich, Elizabeth Campione, Andrea Leifer, and Jane Armer.Lymphatic Research and Biology.
Ahead of print See study
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of an Active Smart Wearable Compression Technology for Treating Breast Cancer Related Lymphedema, a pilot study (N=40) 4
Demonstrated safe and effective use without any adverse events
Showed significant improvement (18%) in overall Quality of Life
Limb volume was maintained or reduced after 28 days of use
Observed 98% adherence over the course of study
Higher is better
p < 0.001
Lower is better
p < 0.001
Subjects were evaluated pre and post use of device (N=7). Indocyanine green (ICG) was administered intradermally and lymphatic pathways and transport of lymph was recorded using a Near-Infrared (NIR) skin camera.5
Observed lymphatic transport in all subjects post device use
Observed subject mobility and treatment limb movement during device use
No adverse events reported
4 Rockson, SG.; Karaca-Mandic, P.; Skoracki, R.; Hock, K.; Nguyen, M.; Shadduck, K.; Gingerich, P.; Campione, E.; Leifer, A.; Armer, J. Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study. Lymphatic Research and Biology 2021, In press.
5 Wigg J.Near-Infrared (NIR) imaging study of the lymphatic movement in patients with Lymphedema. British Lymphology Society. 2020.
Get in touch to learn more or schedule a virtual or in-person demonstration.
